Stocks›Healthcare
WatchAlert

Shukra Pharmaceuticals Limited

SHUKRAPHAR · BSE · Healthcare · As of 8 Nov 2026
₹81.58
+₹1.70 (+2.13%)(1D)
₹26.3052 Week Range₹84.20
Market Cap
₹1,526 Cr
P/E (Sector)
163.2 (32.3)
P/B Ratio
—
Dividend Yield
0.01%
ROE
21.9%
Debt / Equity
—
Anvest Score
59/100
  • Valuation
    0
  • Quality
    94
  • Growth
    100
  • Health
    4
  • Momentum
    94

Fundamentals

P/E Ratio (TTM)
163.16
Sector median P/E
32.29
P/B Ratio
—
Sector median P/B
4.4
EPS (TTM)
₹0.5
Market Cap
₹1,526 Cr
Dividend Yield
0.01%
ROE
21.88%
ROCE
31.83%
Profit Margin
35.98%
Loading technical indicators…
Loading financial statement…
Loading shareholding…
Loading filings…

Shukra Pharmaceuticals Limited FAQs

3 topics
Expand
What does the Shukra Pharmaceuticals Limited (SHUKRAPHAR) stock page cover?
Shukra Pharmaceuticals Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.
What are the current headline metrics for SHUKRAPHAR?
Shukra Pharmaceuticals Limited is currently shown with a delayed price near ₹81.58, P/E 163.16, and ROE 21.88%.
Does the SHUKRAPHAR page provide investment advice?
No. The SHUKRAPHAR page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.
Keep exploring

Related insights